Zymeworks ZYME
NASDAQ ZYME
$29.19 -0.71 (-2.37%)
As of: Sep 4, 2026 · 3:59 PM EDT

Zymeworks (ZYME) Total Liabilities (2021 - 2026)

Zymeworks (ZYME) posted Total Liabilities of $314.6 million for Q1 2026, up 303.23% sequentially from $78.0 million in Q4 2025, and up 212.89% YoY from $100.6 million in Q1 2025.

Analysis

Zymeworks (ZYME) Total Liabilities (2021 - 2026) Analysis & Trends

Zymeworks has reported Total Liabilities for 6 years, with the latest figure at $314.6 million in Q1 2026.

  • Quarterly Total Liabilities rose 212.89% year-over-year to $314.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $314.6 million (up 212.89% YoY) and the FY2025 annual result came in at $78.0 million, down 37.24% from the prior year.
  • Total Liabilities rose to $314.6 million in Q1 2026 per ZYME's latest filing, from $78.0 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $314.6 million in Q1 2026 and troughed at $73.9 million in Q2 2025.
  • A 5-year average of $127.9 million and a median of $120.2 million in 2024 frame the typical range for Total Liabilities.
  • The sharpest annual moves came in 2025 and 2026: Total Liabilities tumbled 37.24% in 2025, then soared 212.89% in 2026.
  • Over 5 years, Total Liabilities stood at $155.8 million in 2022, then decreased by 25.48% to $116.1 million in 2023, then rose by 7.11% to $124.3 million in 2024, then sank by 37.24% to $78.0 million in 2025, then jumped by 303.23% to $314.6 million in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods registered $314.6 million, $78.0 million, and $77.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 7.18 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 10.02 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.62 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 4.20 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 1.72 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 4.00 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 4.20 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 10.03 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.35 Bn
10 Zymeworks 2.13 Bn 1.86 Bn - 316.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 316.60 Mn
Mar 31, 2026 314.63 Mn
Dec 31, 2025 78.03 Mn
Sep 30, 2025 77.21 Mn
Jun 30, 2025 73.88 Mn
Mar 31, 2025 100.56 Mn
Dec 31, 2024 124.32 Mn
Sep 30, 2024 120.17 Mn
Jun 30, 2024 109.47 Mn
Mar 31, 2024 115.75 Mn
Dec 31, 2023 116.07 Mn
Sep 30, 2023 132.02 Mn
Jun 30, 2023 153.14 Mn
Mar 31, 2023 127.21 Mn
Dec 31, 2022 155.77 Mn
Sep 30, 2022 120.51 Mn
Jun 30, 2022 -222.28 Mn
Mar 31, 2022 -282.44 Mn
Dec 31, 2021 140.04 Mn
Sep 30, 2021 -278.93 Mn